NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Gregory Cairncross
University of Calgary - Calgary / Canada
Medical and Health Sciences / Neuroscience
AD Scientific Index ID: 641454
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Gregory Cairncross's MOST POPULAR ARTICLES
1-)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastomaR Stupp, WP Mason, MJ Van Den Bent, M Weller, B Fisher, ...New England journal of medicine 352 (10), 987-996, 2005195262005
2-)
MGMT Gene Silencing and Benefit from Temozolomide in GlioblastomaME Hegi, AC Diserens, T Gorlia, MF Hamou, N De Tribolet, M Weller, ...New England Journal of Medicine 352 (10), 997-1003, 200574682005
3-)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the …R Stupp, ME Hegi, WP Mason, MJ Van Den Bent, MJB Taphoorn, ...The lancet oncology 10 (5), 459-466, 200970962009
4-)
Response criteria for phase II studies of supratentorial malignant glioma.DR Macdonald, TL Cascino, SC Schold Jr, JG CairncrossJournal of clinical oncology 8 (7), 1277-1280, 199028011990
5-)
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomasJG Cairncross, K Ueki, MC Zlatescu, DK Lisle, DM Finkelstein, ...JNCI: Journal of the National Cancer Institute 90 (19), 1473-1479, 199819291998
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept